EcoDrugPlus

Thymidylate Synthetase

Ensembl ID : ENSIPUG00000006627
Gene Symbol: TYMS
3 Cross references
224 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSIPUG00000011865
Gene Symbol: THRB
3 Cross references
392 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor A

Ensembl ID : ENSIPUG00000019908
Gene Symbol: TRHRA
3 Cross references
201 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor B

Ensembl ID : ENSIPUG00000002162
Gene Symbol: TRHRB
1 Cross references
194 Possible Orthologues:

Toll-Like Receptor 2

Ensembl ID : ENSIPUG00000001403
Gene Symbol: TLR2
3 Cross references
199 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSIPUG00000015137
Gene Symbol: TAAR1
1 Cross references
625 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSIPUG00000015098
Gene Symbol: TAAR1
1 Cross references
630 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSIPUG00000015101
Gene Symbol: TAAR1
1 Cross references
625 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSIPUG00000015122
Gene Symbol: TAAR1
1 Cross references
625 Possible Orthologues:

Trace Amine-Associated Receptor 1-Like

Ensembl ID : ENSIPUG00000015082
Gene Symbol: LOC108261192
2 Cross references
635 Possible Orthologues:

Trace Amine-Associated Receptor 11

Ensembl ID : ENSIPUG00000015154
Gene Symbol: TAAR11
4 Cross references
611 Possible Orthologues:

Transforming Growth Factor, Beta Receptor 1 B

Ensembl ID : ENSIPUG00000024933
Gene Symbol: TGFBR1B
3 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).